Literature DB >> 22074484

IDH1 mutations are not found in cartilaginous tumours other than central and periosteal chondrosarcomas and enchondromas.

Stephen Damato, Mohammed Alorjani, Fiona Bonar, Stanley W McCarthy, Stephen R Cannon, Paul O'Donnell, Roberto Tirabosco, M Fernanda Amary, Adrienne M Flanagan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22074484     DOI： 10.1111/j.1365-2559.2011.04010.x

Source DB:  PubMed          Journal:  Histopathology        ISSN： 0309-0167            Impact factor:   5.087


× No keyword cloud information.
  17 in total

Review 1.  Genetic alterations in chondrosarcomas - keys to targeted therapies?

Authors:  Andre M Samuel; Jose Costa; Dieter M Lindskog
Journal:  Cell Oncol (Dordr)       Date:  2014-01-24       Impact factor: 6.730

2.  Recurrent 12q13-15 chromosomal aberrations, high frequency of isocitrate dehydrogenase 1 mutations, and absence of high mobility group AT-hook 2 expression in periosteal chondromas.

Authors:  Ioannis Panagopoulos; Ludmila Gorunova; Ingeborg Taksdal; Bodil Bjerkehagen; Sverre Heim
Journal:  Oncol Lett       Date:  2015-05-11       Impact factor: 2.967

Review 3.  Epigenetics as a New Frontier in Orthopedic Regenerative Medicine and Oncology.

Authors:  Andre J van Wijnen; Jennifer J Westendorf
Journal:  J Orthop Res       Date:  2019-04-25       Impact factor: 3.494

Review 4.  Soft Tissue Special Issue: Chondroid Neoplasms of the Skull.

Authors:  A N Flaman; J K Wasserman; D H Gravel; B M Purgina
Journal:  Head Neck Pathol       Date:  2020-01-16

5.  Imaging features of juxtacortical chondroma in children.

Authors:  Stephen F Miller
Journal:  Pediatr Radiol       Date:  2013-08-17

Review 6.  Hypoxia-driven pathways in bone development, regeneration and disease.

Authors:  Christa Maes; Geert Carmeliet; Ernestina Schipani
Journal:  Nat Rev Rheumatol       Date:  2012-03-27       Impact factor: 20.543

Review 7.  Molecular Pathogenesis and Diagnostic, Prognostic and Predictive Molecular Markers in Sarcoma.

Authors:  Adrián Mariño-Enríquez; Judith V M G Bovée
Journal:  Surg Pathol Clin       Date:  2016-09

Review 8.  The role of metabolic enzymes in mesenchymal tumors and tumor syndromes: genetics, pathology, and molecular mechanisms.

Authors:  Inga-Marie Schaefer; Jason L Hornick; Judith V M G Bovée
Journal:  Lab Invest       Date:  2018-01-16       Impact factor: 5.662

9.  Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors.

Authors:  Mengtao Xiao; Hui Yang; Wei Xu; Shenghong Ma; Huaipeng Lin; Honguang Zhu; Lixia Liu; Ying Liu; Chen Yang; Yanhui Xu; Shimin Zhao; Dan Ye; Yue Xiong; Kun-Liang Guan
Journal:  Genes Dev       Date:  2012-06-07       Impact factor: 12.890

10.  IDH1 immunohistochemistry reactivity and mosaic IDH1 or IDH2 somatic mutations in pediatric sporadic enchondroma and enchondromatosis.

Authors:  Essia Saiji; Fabienne Gumy Pause; Pierre Lascombes; Christelle Cerato Biderbost; Nathalie Lin Marq; Margaret Berczy; Laura Merlini; Anne-Laure Rougemont
Journal:  Virchows Arch       Date:  2019-06-25       Impact factor: 4.535
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.